Preventive role of carvedilol in adriamycin-induced cardiomyopathy

Preventive role of carvedilol in adriamycin-induced cardiomyopathy

Background & objectives: Adriamycin though considered as an effective anticancer drug, leads to irreversible cardiomyopathy (CMP) and congestive heart failure (CHF). The aim of this study was to determine the protective effect of carvedilol in adriamycin (ADR)-induced cardiomyopathy (CMP) in can...

Full description

Bibliographic Details
Main Authors:	Rajesh Jhorawat, Savita Kumari, Subhash C Varma, Manoj K Rohit, Nidhi Narula, Vikas Suri, Pankaj Malhotra, Sanjay Jain
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2016-01-01
Series:	Indian Journal of Medical Research
Subjects:	Adriamycin - cardiomyopathy - carvedilol - chemotherapy - ejection fraction - fraction shortening
Online Access:	http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2016;volume=144;issue=5;spage=725;epage=729;aulast=Jhorawat

Similar Items

The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction
by: Ki Hong Choi, et al.
Published: (2019-09-01)

Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trial
by: Dong-Ju Choi, et al.
Published: (2018-02-01)

Effects of p-blockers metoprolol CR/XL andcarvedilol on left ventricular contractility in patients withchronic cardiac failure
by: A L Syrkin, et al.
Published: (2003-09-01)

Echocardiographic quantitation of left heart size and function in 122 healthy dogs: A prospective study proposing reference intervals and assessing repeatability
by: Lance C. Visser, et al.
Published: (2019-09-01)

The Role of Carvedilol in the Treatment of Dilated and Anthracyclines-Induced Cardiomyopathy
by: Makoto Kodama, et al.
Published: (2011-05-01)

Evaluation of the relationship of echocardiographic left vantricular mass to amounts of transfusions of packed cell and Deferoxamine in Thalassemia major
by: "Kocharian A, et al.
Published: (2001-05-01)

Evaluation of the relationship of echocardiographic left vantricular mass to amounts of transfusions of packed cell and Deferoxamine in Thalassemia major
by: "Kocharian A, et al.
Published: (2001-03-01)

Relationship between echocardiographic findings and laboratory serum biomarkers in patients with and without low cardiac output
by: Mohammad Reza Khalilian, et al.
Published: (2011-01-01)

The effect of prophylactic carvedilol on subclinical left ventricular dysfunction after 1 cycle FAC chemotherapy in breast cancer patients
by: Januar Wibawa Martha, et al.
Published: (2020-08-01)

Adriamycin - efficacy and possible adverse effects
by: Pedrycz Agnieszka, et al.
Published: (2016-03-01)

Adriamycin-induced cardiomyopathy can serve as a model for diabetic cardiomyopathy – a hypothesis
by: Kaviyarasi Renu, et al.
Published: (2017-11-01)

Solanum nigrum Unripe fruit fraction attenuates Adriamycin resistance by down-regulating multi-drug resistance protein (Mdr)-1 through Jak-STAT pathway
by: Sankar Jagadeeshan, et al.
Published: (2017-07-01)

Formulation and evaluation of carvedilol microcapsules using Eudragit NE30D and sodium alginate
by: Trishna Bal, et al.
Published: (2013-12-01)

Predictors and outcomes of sepsis-induced cardiomyopathy in critically ill patients
by: Myung Jin Song, et al.
Published: (2020-05-01)

Effects of the Combination of Gliotoxin and Adriamycin on the Adriamycin-Resistant Non-Small-Cell Lung Cancer A549 Cell Line
by: Le Van Manh Hung, et al.
Published: (2018-03-01)

Adriamycin-induced fetal hydronephrosis
by: Anderson Gonçalves, et al.
Published: (2004-12-01)

Effects of Minimum and Maximum Doses of Furosemide on Fractional Shortening Parameter in Echocardiography of the New Zealand White Rabbit
by: Roham Vali, Mohammad Nasrollahzadeh Masouleh* and Siamak Mashhady Rafie1
Published: (2013-04-01)

Long-term outcomes of non-ischemic dilated cardiomyopathy patients with left ventricular ejection fraction ≤19% on medical therapy
by: Sourabh Agstam, et al.
Published: (2020-11-01)

Clinical and hemodynamic effects of carvedilol in patients with hypertrophic cardiomyopathy
by: T. A. Abdullaev, et al.
Published: (1970-01-01)

Lisinopril Protects Against the Adriamycin Nephropathy and Reverses the Renalase Reduction: Potential Role of Renalase in Adriamycin Nephropathy
by: Pengxun Han, et al.
Published: (2013-09-01)

EFFECT OF SEVOFLURANE EXPOSURE ON ADRIAMYCIN-INDUCED INJURIES TO MYOCYTES
by: Li-hua Fan, et al.
Published: (2014-01-01)

ASSESSMENT OF THE EFFECT OF CARVEDILOL ON THE PERIODONTAL STATUS
by: Cristina-Maria Gavrilescu, et al.
Published: (2015-06-01)

Assessment of the Nutraceutical Effects of Oleuropein and the Cytotoxic Effects of Adriamycin, When Administered Alone and in Combination, in MG-63 Human Osteosarcoma Cells
by: Katerina Gioti, et al.
Published: (2021-01-01)

Plasma levels of free fatty acid differ in patients with left ventricular preserved, mid-range, and reduced ejection fraction
by: Ning Zhu, et al.
Published: (2018-05-01)

Investigation of the Therapeutic Effects of Chloroquine in Adriamycin-Induced Hepatotoxicity
by: Akin Ali Tuğrul, et al.
Published: (2021-01-01)

Adriamycin-resistant cells are significantly less fit than adriamycin-sensitive cells in cervical cancer
by: Qi Min, et al.
Published: (2021-01-01)

Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides
by: Kaiyuan Zhu, et al.
Published: (2021-07-01)

Effect of carvedilol versus nebivolol on insulin resistance among non-diabetic, non-ischemic cardiomyopathy with heart failure
by: Yasser Gaber Metwally, et al.
Published: (2020-09-01)

Clinical characteristics of peripartum cardiomyopathy patients admitted in tertiary hospital
by: Jishu Deb Nath, et al.
Published: (2019-01-01)

Transdermal Delivery of Adriamycin to Transplanted Ehrlich Ascites Tumor in Mice
by: Ryoichi Matsuda, et al.
Published: (2013-07-01)

BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL
by: A. N. Zakirova, et al.
Published: (2016-01-01)

Peripartum cardiomyopathy: A contemporary review
by: Akshai Bhandary, et al.
Published: (2018-01-01)

Afatinib Sensibilizes Multidrug-resistant Human Ovarian Cancer Cells to Adriamycin and Related Mechanisms
by: ZHANG Yunqi, et al.
Published: (2018-10-01)

Investigation of The Effects of Pleurotus Eryngii Extract on Adriamycin-İnduced Cardiotoxicity in Sprague-Dawley Rats
by: Elif Erdem Güzel
Published: (2021-06-01)

Une cardiomyopathie dilatée réversible induite par une hypocalcémie secondaire à une hypoparathyroïdie primaire: à propos d´un cas
by: Ghizlane El Ouazzani, et al.
Published: (2019-12-01)

Desenvolvimento de formulações nanotecnológicas mucoadesivas para administração sublingual de carvedilol
by: Chaves, Paula dos Santos
Published: (2018)

Desenvolvimento de formulações nanotecnológicas mucoadesivas para administração sublingual de carvedilol
by: Chaves, Paula dos Santos
Published: (2018)

Desenvolvimento de formulações nanotecnológicas mucoadesivas para administração sublingual de carvedilol
by: Chaves, Paula dos Santos
Published: (2018)

Attenuation of neuroinflammation reverses Adriamycin-induced cognitive impairments
by: Barrett D. Allen, et al.
Published: (2019-11-01)

Osimertinib-Induced Cardiomyopathy
by: Shruti R. Patel, MD, et al.
Published: (2020-04-01)